S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
LON:IPEL

Impellam Group (IPEL) Share Forecast, Price & News

GBX 450
0.00 (0.00%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
446
450
50-Day Range
413
457
52-Week Range
270
525
Volume
655 shs
Average Volume
9,076 shs
Market Capitalization
£203.17 million
P/E Ratio
25.00
Dividend Yield
4.48%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive IPEL News and Ratings via Email

Sign-up to receive the latest news and ratings for Impellam Group and its competitors with MarketBeat's FREE daily newsletter.

About Impellam Group

Impellam Group plc provides staffing solutions, human capital management, and outsourced people-related services in the United Kingdom, North America, rest of Europe, and Australasia. It operates through four segments: Global Managed Services, STEM, Regional Specialist Staffing, and Healthcare. The Global Managed Services segment engages in the design, implement, coordinate, and report on the talent acquisition process through the provision of multi-disciplinary outsourced recruitment services under the Comensura, Guidant Global, and Flexy brand names. The STEM provides specialist contract and permanent recruitment services of scientists, clinicians, engineers, IT, and digital specialists under the Lorien, Carbon60, Bartech, and SRG brand names. The Regional Specialist Staffing segment offers staffing services for warehouse workers, secretaries, call centre operatives, lawyers, drivers, teachers, chefs, and HR and marketing professionals under the Blue Arrow, Tate, Career Teacher, and Chadwick Nott brand names. The Healthcare segment provides healthcare workforce solutions, including healthcare staffing, managed services, staff bank, occupational health, insourcing, social care, and home care services under the Medacs Healthcare, Global Medics, and Litmus Workforce Solutions brand names. This segment also recruits locum, temporary and permanent doctors, nurses, care workers, and allied health professionals. The company was incorporated in 2008 and is based in Luton, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Staffing & Outsourcing Services
Sub-Industry
N/A
Sector
Services
CIK
N/A
Fax
N/A
Employees
2,500
Year Founded
N/A

Sales & Book Value

Annual Sales
£2.26 billion
Cash Flow
GBX 201.14 per share
Book Value
GBX 493.70 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£203.17 million
Optionable
Not Optionable

Company Calendar

Today
5/21/2022
Next Earnings (Estimated)
7/27/2022

MarketRank

Overall MarketRank

1.46 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -













Impellam Group (LON:IPEL) Frequently Asked Questions

When is Impellam Group's next earnings date?

Impellam Group is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Impellam Group
.

Who are Impellam Group's key executives?
Impellam Group's management team includes the following people:
  • Ms. Julia Robertson, Group CEO & Exec. Director (Age 63, Pay $1.12M)
  • Mr. Tim Briant, CFO & Director
  • Ms. Rebecca J. Watson, Portfolio CEO, Group Gen. Counsel, Company Sec. & Director (Age 53)
  • Ms. Penny Queller, Chief Customer Officer
  • Mr. Simon Blockley, Chief Exec. Officer of Global Managed Services
  • Ms. Ann Bookout, Global Head of Culture & Fulfillment
  • Ms. Claire Marsh, Chief Exec. Officer of North America
  • Mr. Danny Cohen, Managing Director of STEM - North America
  • Ms. Tracy Monsour, Sr. VP of Marketing - North America
What other stocks do shareholders of Impellam Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Impellam Group investors own include Akebia Therapeutics (AKBA), Newmont (NEM), Bridgestone (BRDCY), Bemis (BMS), Banco de Chile (BCH), ArrowMark Financial (BANX), AVX (AVX), Allianz (ALV), AltaGas (ALA) and Arthur J. Gallagher & Co. (AJG).

What is Impellam Group's stock symbol?

Impellam Group trades on the London Stock Exchange (LON) under the ticker symbol "IPEL."

How do I buy shares of Impellam Group?

Shares of IPEL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Impellam Group's stock price today?

One share of IPEL stock can currently be purchased for approximately GBX 450.

How much money does Impellam Group make?

Impellam Group has a market capitalization of £203.17 million and generates £2.26 billion in revenue each year.

How many employees does Impellam Group have?

Impellam Group employs 2,500 workers across the globe.

What is Impellam Group's official website?

The official website for Impellam Group is www.impellam.com.

How can I contact Impellam Group?

Impellam Group's mailing address is The Boulevard, 800 Capability Green, LUTON, LU1 3BA, United Kingdom. The company can be reached via phone at +44-1582-692692.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.